Welcome to this episode of Talking Meds and the PrescQIPP podcast, engaging conversations about medicines-related dilemmas. In this, the first episode for 2026, we welcome back three former guests to look ahead to 2026 and they give us their thoughts on what might happen in terms of medicines and prescribing. Philip Newland-Jones joined us back in April 2025 for Episode 16 where we discussed the management of obesity. Philip is a Consultant Pharmacist in Diabetes and Endocrinology and i...
All content for Talking Meds - A PrescQIPP podcast is the property of PrescQIPP C.I.C. and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to this episode of Talking Meds and the PrescQIPP podcast, engaging conversations about medicines-related dilemmas. In this, the first episode for 2026, we welcome back three former guests to look ahead to 2026 and they give us their thoughts on what might happen in terms of medicines and prescribing. Philip Newland-Jones joined us back in April 2025 for Episode 16 where we discussed the management of obesity. Philip is a Consultant Pharmacist in Diabetes and Endocrinology and i...
23. How community pharmacy can buck the inverse care law with Prof Adam Todd
Talking Meds - A PrescQIPP podcast
35 minutes
5 months ago
23. How community pharmacy can buck the inverse care law with Prof Adam Todd
Welcome to the latest episode of Talking Meds and the PrescQIPP podcast, engaging conversations about medicines-related dilemmas. Today, your host Jonathan Underhill, Medicines Clinical Adviser at PrescQIPP, talks to Prof Adam Todd about inequalities in the use of medicines and the role of pharmacy in addressing that. Adam Todd is a Professor of Pharmaceutical Public Health, and Deputy Head of the School of Pharmacy at Newcastle University. He is a qualified pharmacist and a Fellow of the Ro...
Talking Meds - A PrescQIPP podcast
Welcome to this episode of Talking Meds and the PrescQIPP podcast, engaging conversations about medicines-related dilemmas. In this, the first episode for 2026, we welcome back three former guests to look ahead to 2026 and they give us their thoughts on what might happen in terms of medicines and prescribing. Philip Newland-Jones joined us back in April 2025 for Episode 16 where we discussed the management of obesity. Philip is a Consultant Pharmacist in Diabetes and Endocrinology and i...
